CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: benzaldehydes
Accession: CHEBI:22698
browse the term
Definition: Any arenecarbaldehyde that consists of a formyl substituted benzene ring and its substituted derivatives thereof.
Synonyms: xref_mesh: MESH:D001547
G
Aldh1a2
aldehyde dehydrogenase 1 family, member A2
decreases activity
ISO
Benzaldehydes results in decreased activity of ALDH1A2 protein
CTD
PMID:22079344
NCBI chr 8:71,877,850...71,957,107
Ensembl chr 8:71,877,850...71,957,107
G
Aldh2
aldehyde dehydrogenase 2 family member
decreases activity
ISO
Benzaldehydes results in decreased activity of ALDH2 protein
CTD
PMID:22079344
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
G
Aldh2
aldehyde dehydrogenase 2 family member
increases metabolic processing
ISO
ALDH2 protein results in increased metabolism of 2,5-dihydroxybenzaldehyde
CTD
PMID:11744614
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
G
Akr7a2
aldo-keto reductase family 7, member A2
increases reduction affects reduction
ISO
AKR7A2 protein results in increased reduction of 2-nitrobenzaldehyde 2-nitrobenzaldehyde affects the reduction of AKR7A5 protein
CTD
PMID:10510318 PMID:12604212
NCBI chr 5:151,552,375...151,560,914
Ensembl chr 5:151,552,343...151,560,909
G
Ache
acetylcholinesterase
multiple interactions
ISO
protocatechualdehyde inhibits the reaction [Potassium Dichromate results in decreased activity of ACHE protein]; protocatechualdehyde inhibits the reaction [sodium arsenite results in decreased activity of ACHE protein]
CTD
PMID:29665407 PMID:29732668
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
G
Acta2
actin alpha 2, smooth muscle
multiple interactions
EXP
protocatechualdehyde inhibits the reaction [Bleomycin results in increased expression of ACTA2 protein]
CTD
PMID:25582705
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
G
Ager
advanced glycosylation end product-specific receptor
multiple interactions
ISO EXP
protocatechualdehyde inhibits the reaction [S100B protein results in increased expression of AGER mRNA]; protocatechualdehyde inhibits the reaction [S100B protein results in increased expression of AGER protein]; protocatechualdehyde inhibits the reaction [TGFB1 protein results in decreased expression of AGER protein] protocatechualdehyde inhibits the reaction [Bleomycin results in decreased expression of AGER protein]
CTD
PMID:17597607 PMID:25582705
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
G
Cat
catalase
multiple interactions increases activity
ISO
protocatechualdehyde inhibits the reaction [Potassium Dichromate results in decreased activity of CAT protein]; protocatechualdehyde inhibits the reaction [sodium arsenite results in decreased activity of CAT protein] protocatechualdehyde results in increased activity of CAT protein
CTD
PMID:29665407 PMID:29732668
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Cdh1
cadherin 1
multiple interactions
ISO
protocatechualdehyde inhibits the reaction [TGFB1 protein results in decreased expression of CDH1 protein]
CTD
PMID:25582705
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
G
Fgf2
fibroblast growth factor 2
multiple interactions
ISO EXP
protocatechualdehyde inhibits the reaction [TGFB1 protein results in increased expression of FGF2 protein] protocatechualdehyde inhibits the reaction [Bleomycin results in increased expression of FGF2 protein]
CTD
PMID:25582705
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
G
G6pd
glucose-6-phosphate dehydrogenase
multiple interactions
ISO
protocatechualdehyde inhibits the reaction [Potassium Dichromate results in decreased activity of G6PD protein]; protocatechualdehyde inhibits the reaction [sodium arsenite results in decreased activity of G6PD protein]
CTD
PMID:29665407 PMID:29732668
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
G
Glo1
glyoxalase 1
multiple interactions
ISO
protocatechualdehyde inhibits the reaction [sodium arsenite results in increased activity of GLO1 protein]
CTD
PMID:29732668
NCBI chr20:8,663,617...8,681,661
Ensembl chr20:8,662,801...8,681,649
G
Gsr
glutathione-disulfide reductase
multiple interactions
ISO
protocatechualdehyde inhibits the reaction [Potassium Dichromate results in decreased activity of GSR protein]; protocatechualdehyde inhibits the reaction [sodium arsenite results in decreased activity of GSR protein]
CTD
PMID:29665407 PMID:29732668
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
Hmgb1
high mobility group box 1
multiple interactions
EXP ISO
protocatechualdehyde inhibits the reaction [Bleomycin results in increased expression of HMGB1 protein] protocatechualdehyde inhibits the reaction [TGFB1 protein results in increased expression of HMGB1 protein]
CTD
PMID:25582705
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
S100b
S100 calcium binding protein B
multiple interactions
ISO
protocatechualdehyde inhibits the reaction [S100B protein results in increased expression of AGER mRNA]; protocatechualdehyde inhibits the reaction [S100B protein results in increased expression of AGER protein]; protocatechualdehyde inhibits the reaction [S100B protein results in increased expression of TGFB1 mRNA]; protocatechualdehyde inhibits the reaction [S100B protein results in increased expression of TGFB1 protein]; protocatechualdehyde inhibits the reaction [S100B protein results in increased phosphorylation of and affects the localization of SMAD2 protein]; protocatechualdehyde inhibits the reaction [S100B protein results in increased phosphorylation of and affects the localization of SMAD3 protein]
CTD
PMID:17597607
NCBI chr20:12,372,866...12,381,619
Ensembl chr20:12,372,881...12,394,743
G
Smad2
SMAD family member 2
multiple interactions
ISO
protocatechualdehyde inhibits the reaction [Glucose results in increased phosphorylation of and affects the localization of SMAD2 protein]; protocatechualdehyde inhibits the reaction [S100B protein results in increased phosphorylation of and affects the localization of SMAD2 protein]
CTD
PMID:17597607
NCBI chr18:69,849,884...69,918,926
Ensembl chr18:69,850,377...69,912,323
G
Smad3
SMAD family member 3
multiple interactions
ISO
protocatechualdehyde inhibits the reaction [Glucose results in increased phosphorylation of and affects the localization of SMAD3 protein]; protocatechualdehyde inhibits the reaction [S100B protein results in increased phosphorylation of and affects the localization of SMAD3 protein]
CTD
PMID:17597607
NCBI chr 8:64,126,829...64,236,960
Ensembl chr 8:64,110,039...64,236,960
G
Sod1
superoxide dismutase 1
multiple interactions
ISO
protocatechualdehyde inhibits the reaction [Potassium Dichromate results in increased activity of SOD1 protein]; protocatechualdehyde inhibits the reaction [sodium arsenite results in decreased activity of SOD1 protein]
CTD
PMID:29665407 PMID:29732668
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Tgfb1
transforming growth factor, beta 1
multiple interactions
ISO
protocatechualdehyde inhibits the reaction [Glucose results in increased expression of TGFB1 mRNA]; protocatechualdehyde inhibits the reaction [Glucose results in increased expression of TGFB1 protein]; protocatechualdehyde inhibits the reaction [S100B protein results in increased expression of TGFB1 mRNA]; protocatechualdehyde inhibits the reaction [S100B protein results in increased expression of TGFB1 protein]; protocatechualdehyde inhibits the reaction [TGFB1 protein results in decreased expression of AGER protein]; protocatechualdehyde inhibits the reaction [TGFB1 protein results in decreased expression of CDH1 protein]; protocatechualdehyde inhibits the reaction [TGFB1 protein results in increased expression of FGF2 protein]; protocatechualdehyde inhibits the reaction [TGFB1 protein results in increased expression of HMGB1 protein]; protocatechualdehyde inhibits the reaction [TGFB1 protein results in increased expression of VIM protein]
CTD
PMID:17597607 PMID:25582705
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Vim
vimentin
multiple interactions
ISO
protocatechualdehyde inhibits the reaction [TGFB1 protein results in increased expression of VIM protein]
CTD
PMID:25582705
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
G
Ar
androgen receptor
multiple interactions
ISO
3,5-di-tert-butyl-4-hydroxybenzaldehyde binds to and results in decreased activity of AR protein
CTD
PMID:27633901
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Esr1
estrogen receptor 1
multiple interactions
ISO
3,5-di-tert-butyl-4-hydroxybenzaldehyde binds to and results in decreased activity of ESR1 protein
CTD
PMID:27633901
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
multiple interactions
ISO
3,5-di-tert-butyl-4-hydroxybenzaldehyde binds to and results in decreased activity of NR3C1 protein
CTD
PMID:27633901
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
G
Pgr
progesterone receptor
multiple interactions
ISO
3,5-di-tert-butyl-4-hydroxybenzaldehyde binds to and results in decreased activity of PGR protein
CTD
PMID:27633901
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
G
Pparg
peroxisome proliferator-activated receptor gamma
multiple interactions
ISO
3,5-di-tert-butyl-4-hydroxybenzaldehyde binds to and results in decreased activity of PPARG protein
CTD
PMID:27633901
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Thrb
thyroid hormone receptor beta
multiple interactions
ISO
3,5-di-tert-butyl-4-hydroxybenzaldehyde binds to and results in decreased activity of THRB protein
CTD
PMID:27633901
NCBI chr15:7,685,180...8,031,920
Ensembl chr15:7,685,180...7,882,916
G
Aldh2
aldehyde dehydrogenase 2 family member
increases metabolic processing
ISO
ALDH2 protein results in increased metabolism of 3-hydroxybenzaldehyde
CTD
PMID:11744614
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
G
Akr1a1
aldo-keto reductase family 1 member A1
increases reduction
ISO
AKR1A1 protein results in increased reduction of 3-nitrobenzaldehyde
CTD
PMID:10510318
NCBI chr 5:130,092,945...130,130,277
Ensembl chr 5:130,092,732...130,113,674
G
Akr1b1
aldo-keto reductase family 1 member B1
increases reduction
ISO
AKR1B1 protein results in increased reduction of 3-nitrobenzaldehyde
CTD
PMID:10510318
NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:62,932,031...62,946,157
G
Akr7a2
aldo-keto reductase family 7, member A2
affects reduction
ISO
3-nitrobenzaldehyde affects the reduction of AKR7A5 protein; 3-nitrobenzaldehyde analog affects the reduction of AKR7A5 protein
CTD
PMID:12604212
NCBI chr 5:151,552,375...151,560,914
Ensembl chr 5:151,552,343...151,560,909
G
Aldh1a1
aldehyde dehydrogenase 1 family, member A1
decreases activity multiple interactions increases oxidation
ISO
4-(diethylamino)benzaldehyde results in decreased activity of ALDH1A1 protein 4-(diethylamino)benzaldehyde inhibits the reaction [ALDH1A1 protein results in decreased susceptibility to mafosfamide] ALDH1A1 protein results in increased oxidation of 4-(diethylamino)benzaldehyde
CTD
PMID:8662658 PMID:16316642 PMID:25512087
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
G
Aldh1a2
aldehyde dehydrogenase 1 family, member A2
multiple interactions
ISO
4-(diethylamino)benzaldehyde binds to and results in decreased activity of ALDH1A2 protein
CTD
PMID:25512087
NCBI chr 8:71,877,850...71,957,107
Ensembl chr 8:71,877,850...71,957,107
G
Aldh2
aldehyde dehydrogenase 2 family member
multiple interactions
ISO
4-(diethylamino)benzaldehyde binds to and results in decreased activity of ALDH2 protein
CTD
PMID:25512087
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
G
Aldh3a1
aldehyde dehydrogenase 3 family, member A1
increases oxidation
ISO
ALDH3A1 protein results in increased oxidation of 4-(diethylamino)benzaldehyde
CTD
PMID:25512087
NCBI chr10:45,892,993...45,902,680
Ensembl chr10:45,892,924...45,902,681
G
Akr1a1
aldo-keto reductase family 1 member A1
increases reduction
ISO
AKR1A1 protein results in increased reduction of 4-carboxybenzaladehyde
CTD
PMID:10510318
NCBI chr 5:130,092,945...130,130,277
Ensembl chr 5:130,092,732...130,113,674
G
Akr1a1
aldo-keto reductase family 1 member A1
increases reduction
ISO
AKR1A1 protein results in increased reduction of 4-nitrobenzaldehyde
CTD
PMID:10510318
NCBI chr 5:130,092,945...130,130,277
Ensembl chr 5:130,092,732...130,113,674
G
Akr1b1
aldo-keto reductase family 1 member B1
increases reduction
ISO
AKR1B1 protein results in increased reduction of 4-nitrobenzaldehyde
CTD
PMID:10510318
NCBI chr 4:62,932,033...62,946,126
Ensembl chr 4:62,932,031...62,946,157
G
Akr1b8
aldo-keto reductase family 1, member B8
increases metabolic processing
ISO
AKR1B15 protein results in increased metabolism of 4-nitrobenzaldehyde
CTD
PMID:21276782
NCBI chr 4:62,997,241...63,009,815
Ensembl chr 4:62,997,161...63,010,097
G
Akr7a2
aldo-keto reductase family 7, member A2
multiple interactions affects reduction
ISO
Ethacrynic Acid inhibits the reaction [4-nitrobenzaldehyde affects the reduction of AKR7A5 protein]; Indomethacin inhibits the reaction [4-nitrobenzaldehyde affects the reduction of AKR7A5 protein]; Quercetin inhibits the reaction [4-nitrobenzaldehyde affects the reduction of AKR7A5 protein]; Valproic Acid inhibits the reaction [4-nitrobenzaldehyde affects the reduction of AKR7A5 protein]
CTD
PMID:12604212
NCBI chr 5:151,552,375...151,560,914
Ensembl chr 5:151,552,343...151,560,909
G
Dhrs7
dehydrogenase/reductase 7
increases reduction
ISO
DHRS7 protein results in increased reduction of 4-nitrobenzaldehyde
CTD
PMID:24246760
NCBI chr 6:91,332,259...91,347,856
Ensembl chr 6:91,251,323...91,347,892
G
Dyrk2
dual specificity tyrosine phosphorylation regulated kinase 2
multiple interactions
ISO
[Curcumin binds to 4-nitrobenzaldehyde] which results in decreased activity of DYRK2 protein
CTD
PMID:33617879
NCBI chr 7:54,348,724...54,381,363
Ensembl chr 7:54,349,610...54,380,106
G
Nfe2l2
NFE2 like bZIP transcription factor 2
multiple interactions
ISO
NFE2L2 protein promotes the reaction [sulforaphane results in decreased susceptibility to 4-nitrobenzaldehyde]
CTD
PMID:20932822
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Aldh1a1
aldehyde dehydrogenase 1 family, member A1
increases oxidation increases metabolic processing
EXP ISO
ALDH1A1 protein results in increased oxidation of benzaldehyde ALDH1A1 protein results in increased metabolism of benzaldehyde
CTD
PMID:10998257 PMID:21256123
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
G
Aldh2
aldehyde dehydrogenase 2 family member
increases metabolic processing multiple interactions
ISO
ALDH2 protein results in increased metabolism of benzaldehyde benzaldehyde inhibits the reaction [4-dimethylaminocinnamaldehyde binds to ALDH2 protein]
CTD
PMID:10609638 PMID:11744614
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
G
Aldh3a1
aldehyde dehydrogenase 3 family, member A1
multiple interactions increases oxidation increases metabolic processing
ISO
[ALDH3A1 protein co-treated with NAD] results in increased oxidation of benzaldehyde; [ALDH3A1 protein co-treated with NADP] results in increased oxidation of benzaldehyde; Cimetidine inhibits the reaction [ALDH3A1 protein results in increased oxidation of benzaldehyde] ALDH3A1 protein results in increased metabolism of benzaldehyde
CTD
PMID:10856427 PMID:21256123 PMID:21349255 PMID:23220590 PMID:25512087
NCBI chr10:45,892,993...45,902,680
Ensembl chr10:45,892,924...45,902,681
G
Aldh3b1
aldehyde dehydrogenase 3 family, member B1
affects binding
ISO
benzaldehyde binds to ALDH3B1 protein
CTD
PMID:20699116
NCBI chr 1:201,145,309...201,162,675
Ensembl chr 1:201,145,309...201,163,921
G
Ar
androgen receptor
multiple interactions
EXP
benzaldehyde inhibits the reaction [Metribolone binds to AR protein]
CTD
PMID:3695475
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Slc2a1
solute carrier family 2 member 1
increases activity multiple interactions
ISO
benzaldehyde results in increased activity of SLC2A1 protein [benzaldehyde co-treated with Glucose deficiency] results in decreased activity of SLC2A1 protein
CTD
PMID:20955755
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
G
Or5d18
olfactory receptor family 5 subfamily D member 18
multiple interactions
ISO
[ethyl vanillin binds to and results in increased activity of OR5D18 protein] which results in increased transport of Calcium; ethyl vanillin binds to and results in increased activity of OR5D18 protein
CTD
PMID:15716417
NCBI chr 3:73,516,522...73,517,463
Ensembl chr 3:73,516,364...73,519,858 Ensembl chr 3:73,516,364...73,519,858
G
Trpv3
transient receptor potential cation channel, subfamily V, member 3
increases activity
ISO
ethyl vanillin results in increased activity of TRPV3 protein
CTD
PMID:16617338
NCBI chr10:57,883,546...57,915,865
Ensembl chr10:57,883,546...57,913,296
G
Cyp2b1
cytochrome P450, family 2, subfamily b, polypeptide 1
decreases activity
EXP
3-methylbenzaldehyde results in decreased activity of CYP2B1 protein
CTD
PMID:12791539
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
decreases activity
EXP
3-methylbenzaldehyde results in decreased activity of CYP2E1 protein
CTD
PMID:12791539
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Cyp4b1
cytochrome P450, family 4, subfamily b, polypeptide 1
affects activity
EXP
3-methylbenzaldehyde affects the activity of CYP4B1 protein
CTD
PMID:12791539
NCBI chr 5:129,139,019...129,176,860
Ensembl chr 5:129,139,038...129,156,348
G
Ugt1a2
UDP glucuronosyltransferase 1 family, polypeptide A2
increases glucuronidation
ISO
UGT1A3 protein results in increased glucuronidation of 2-vanillin
CTD
PMID:15117964
NCBI chr 9:88,791,216...88,808,465
Ensembl chr 9:88,713,184...88,808,465
G
Trpa1
transient receptor potential cation channel, subfamily A, member 1
increases activity
ISO
4-anisaldehyde results in increased activity of TRPA1 protein
CTD
PMID:21591660
NCBI chr 5:4,379,862...4,434,133
Ensembl chr 5:4,379,999...4,433,570
G
Ahr
aryl hydrocarbon receptor
multiple interactions
ISO
4-methylbenzaldehyde binds to and results in decreased activity of AHR protein
CTD
PMID:27633901
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
G
Ar
androgen receptor
multiple interactions
ISO
4-methylbenzaldehyde binds to and results in decreased activity of AR protein
CTD
PMID:27633901
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Esr2
estrogen receptor 2
multiple interactions
ISO
4-methylbenzaldehyde binds to and results in decreased activity of ESR2 protein
CTD
PMID:27633901
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
G
Il1b
interleukin 1 beta
multiple interactions
ISO
4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; 4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; 4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of IL1B protein]
CTD
PMID:27569861
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
multiple interactions
ISO
4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; 4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 protein]
CTD
PMID:27569861
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
ISO
4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK1 protein]
CTD
PMID:27569861
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
ISO
4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MAPK3 protein]
CTD
PMID:27569861
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Nfkb1
nuclear factor kappa B subunit 1
multiple interactions
ISO
4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides affects the localization of NFKB1 protein]
CTD
PMID:27569861
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Nfkbia
NFKB inhibitor alpha
multiple interactions
ISO
4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased degradation of NFKBIA protein]
CTD
PMID:27569861
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nos2
nitric oxide synthase 2
multiple interactions
ISO
4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; 4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]
CTD
PMID:27569861
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Pgr
progesterone receptor
multiple interactions
ISO
4-methylbenzaldehyde binds to and results in decreased activity of PGR protein
CTD
PMID:27633901
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
G
Pparg
peroxisome proliferator-activated receptor gamma
multiple interactions
ISO
4-methylbenzaldehyde binds to and results in decreased activity of PPARG protein
CTD
PMID:27633901
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
ISO
4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; 4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein]
CTD
PMID:27569861
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO
4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides affects the localization of RELA protein]
CTD
PMID:27569861
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Tnf
tumor necrosis factor
multiple interactions
ISO
4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; 4-methylbenzaldehyde analog inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]
CTD
PMID:27569861
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Aicda
activation-induced cytidine deaminase
affects expression
ISO
o-Phthalaldehyde affects the expression of AICDA mRNA
CTD
PMID:22302311
NCBI chr 4:155,774,132...155,783,972
Ensembl chr 4:155,774,132...155,783,972
G
Akr1c3
aldo-keto reductase family 1, member C3
affects expression
ISO
o-Phthalaldehyde affects the expression of AKR1C18 mRNA
CTD
PMID:22302311
NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
G
Ccl9
C-C motif chemokine ligand 9
affects expression
ISO
o-Phthalaldehyde affects the expression of CCL6 mRNA
CTD
PMID:22302311
NCBI chr10:68,366,486...68,371,408
Ensembl chr10:68,366,487...68,371,369
G
Ccna2
cyclin A2
affects expression
ISO
o-Phthalaldehyde affects the expression of CCNA2 mRNA
CTD
PMID:22302311
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
G
Ccnb1
cyclin B1
affects expression
ISO
o-Phthalaldehyde affects the expression of CCNB1 mRNA
CTD
PMID:22302311
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
G
Ccne2
cyclin E2
affects expression
ISO
o-Phthalaldehyde affects the expression of CCNE2 mRNA
CTD
PMID:22302311
NCBI chr 5:24,285,078...24,298,258
Ensembl chr 5:24,284,922...24,297,632
G
Ccr4
C-C motif chemokine receptor 4
affects expression
ISO
o-Phthalaldehyde affects the expression of CCR4 mRNA
CTD
PMID:22302311
NCBI chr 8:114,176,291...114,182,033
Ensembl chr 8:114,176,974...114,178,056
G
Cd207
CD207 molecule
affects expression
ISO
o-Phthalaldehyde affects the expression of CD207 mRNA
CTD
PMID:22302311
NCBI chr 4:116,155,229...116,161,587
Ensembl chr 4:116,155,212...116,161,518
G
Cd5l
Cd5 molecule-like
affects expression
ISO
o-Phthalaldehyde affects the expression of CD5L mRNA
CTD
PMID:22302311
NCBI chr 2:172,791,007...172,802,018
Ensembl chr 2:172,790,934...172,829,753
G
Cd83
CD83 molecule
affects expression
ISO
o-Phthalaldehyde affects the expression of CD83 mRNA
CTD
PMID:22302311
NCBI chr17:20,887,309...20,907,009
Ensembl chr17:20,887,309...20,907,083
G
Cdc20
cell division cycle 20
affects expression
ISO
o-Phthalaldehyde affects the expression of CDC20 mRNA
CTD
PMID:22302311
NCBI chr 5:131,966,203...131,970,406
Ensembl chr 5:131,966,215...131,970,512
G
Cdc25c
cell division cycle 25C
affects expression
ISO
o-Phthalaldehyde affects the expression of CDC25C mRNA
CTD
PMID:22302311
NCBI chr18:26,335,156...26,356,199
Ensembl chr18:26,335,834...26,356,185
G
Cdk1
cyclin-dependent kinase 1
affects expression
ISO
o-Phthalaldehyde affects the expression of CDK1 mRNA
CTD
PMID:22302311
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
G
Clec7a
C-type lectin domain containing 7A
affects expression
ISO
o-Phthalaldehyde affects the expression of CLEC7A mRNA
CTD
PMID:22302311
NCBI chr 4:162,902,731...162,913,931
Ensembl chr 4:162,902,732...162,913,897
G
Col8a1
collagen type VIII alpha 1 chain
affects expression
ISO
o-Phthalaldehyde affects the expression of COL8A1 mRNA
CTD
PMID:22302311
NCBI chr11:42,776,851...42,906,432
Ensembl chr11:42,777,628...42,906,424
G
Cphx1
cytoplasmic polyadenylated homeobox 1
affects expression
ISO
o-Phthalaldehyde affects the expression of CPHX1 mRNA
CTD
PMID:22302311
NCBI chr16:1,533,883...1,537,248
Ensembl chr16:1,528,440...1,537,082
G
Ctla4
cytotoxic T-lymphocyte-associated protein 4
affects expression
ISO
o-Phthalaldehyde affects the expression of CTLA4 mRNA
CTD
PMID:22302311
NCBI chr 9:62,318,874...62,325,978
Ensembl chr 9:62,319,312...62,324,963
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
decreases expression
ISO
o-Phthalaldehyde results in decreased expression of CYP1A1 mRNA
CTD
PMID:20112102
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
decreases expression
ISO
o-Phthalaldehyde results in decreased expression of CYP2E1 mRNA
CTD
PMID:20112102
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Dio1
iodothyronine deiodinase 1
decreases activity
ISO
o-Phthalaldehyde results in decreased activity of DIO1 protein
CTD
PMID:30561685
NCBI chr 5:122,074,285...122,090,983
Ensembl chr 5:122,074,279...122,090,970
G
Dio2
iodothyronine deiodinase 2
decreases activity
ISO
o-Phthalaldehyde results in decreased activity of DIO2 protein
CTD
PMID:30561685
NCBI chr 6:109,665,523...109,679,809
Ensembl chr 6:109,665,523...109,679,809
G
Dio3
iodothyronine deiodinase 3
decreases activity
ISO
o-Phthalaldehyde results in decreased activity of DIO3 protein
CTD
PMID:30561685
NCBI chr 6:129,285,747...129,287,608
Ensembl chr 6:129,285,749...129,286,660
G
E2f1
E2F transcription factor 1
affects expression
ISO
o-Phthalaldehyde affects the expression of E2F1 mRNA
CTD
PMID:22302311
NCBI chr 3:143,064,535...143,075,362
Ensembl chr 3:143,049,478...143,075,361
G
Fabp7
fatty acid binding protein 7
affects expression
ISO
o-Phthalaldehyde affects the expression of FABP7 mRNA
CTD
PMID:22302311
NCBI chr20:37,123,193...37,126,725
Ensembl chr20:37,123,193...37,126,880
G
Fxyd4
FXYD domain-containing ion transport regulator 4
affects expression
ISO
o-Phthalaldehyde affects the expression of FXYD4 mRNA
CTD
PMID:22302311
NCBI chr 4:151,109,779...151,113,659
Ensembl chr 4:151,109,779...151,113,637
G
Gzmb
granzyme B
affects expression
ISO
o-Phthalaldehyde affects the expression of GZMB mRNA
CTD
PMID:22302311
NCBI chr15:30,343,352...30,346,814
Ensembl chr15:30,173,603...30,346,814
G
Ifng
interferon gamma
increases expression
ISO
o-Phthalaldehyde results in increased expression of IFNG mRNA
CTD
PMID:21785612
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Il10
interleukin 10
increases expression
ISO
o-Phthalaldehyde results in increased expression of IL10 mRNA
CTD
PMID:21785612
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il12b
interleukin 12B
affects expression
ISO
o-Phthalaldehyde affects the expression of IL12B mRNA
CTD
PMID:22302311
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
G
Il13
interleukin 13
increases expression
ISO
o-Phthalaldehyde results in increased expression of IL13 mRNA
CTD
PMID:21785612
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
G
Il1b
interleukin 1 beta
increases expression
ISO
o-Phthalaldehyde results in increased expression of IL1B mRNA
CTD
PMID:21785612
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il21
interleukin 21
affects expression
ISO
o-Phthalaldehyde affects the expression of IL21 mRNA
CTD
PMID:22302311
NCBI chr 2:120,117,105...120,127,012
Ensembl chr 2:120,119,444...120,126,996
G
Il2ra
interleukin 2 receptor subunit alpha
affects expression
ISO
o-Phthalaldehyde affects the expression of IL2RA mRNA
CTD
PMID:22302311
NCBI chr17:66,849,974...66,898,665
Ensembl chr17:66,849,974...66,898,697
G
Il4
interleukin 4
affects expression increases expression
ISO
o-Phthalaldehyde affects the expression of IL4 mRNA o-Phthalaldehyde results in increased expression of IL4 mRNA; o-Phthalaldehyde results in increased expression of IL4 protein
CTD
PMID:19110043 PMID:20176622 PMID:21785612 PMID:22302311
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Il5
interleukin 5
increases expression
ISO
o-Phthalaldehyde results in increased expression of IL5 mRNA
CTD
PMID:19110043 PMID:21785612
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
G
Itgav
integrin subunit alpha V
affects expression
ISO
o-Phthalaldehyde affects the expression of ITGAV mRNA
CTD
PMID:22302311
NCBI chr 3:68,838,514...68,926,653
Ensembl chr 3:68,838,189...68,926,639
G
Iyd
iodotyrosine deiodinase
multiple interactions
ISO
o-Phthalaldehyde inhibits the reaction [IYD protein results in increased metabolism of Monoiodotyrosine]
CTD
PMID:33352258
NCBI chr 1:40,003,999...40,019,323
Ensembl chr 1:40,004,041...40,019,319
G
Lgals7
galectin 7
affects expression
ISO
o-Phthalaldehyde affects the expression of LGALS7 mRNA
CTD
PMID:22302311
NCBI chr 1:84,148,612...84,152,016
Ensembl chr 1:84,150,252...84,152,015
G
Mki67
marker of proliferation Ki-67
affects expression
ISO
o-Phthalaldehyde affects the expression of MKI67 mRNA
CTD
PMID:22302311
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
G
Nts
neurotensin
affects expression
ISO
o-Phthalaldehyde affects the expression of NTS mRNA
CTD
PMID:22302311
NCBI chr 7:37,564,944...37,574,350
Ensembl chr 7:37,564,533...37,574,423
G
Thbs1
thrombospondin 1
affects expression
ISO
o-Phthalaldehyde affects the expression of THBS1 mRNA
CTD
PMID:22302311
NCBI chr 3:105,056,293...105,071,445
Ensembl chr 3:105,056,292...105,071,440
G
Thbs4
thrombospondin 4
affects expression
ISO
o-Phthalaldehyde affects the expression of THBS4 mRNA
CTD
PMID:22302311
NCBI chr 2:23,983,158...24,025,289
Ensembl chr 2:23,983,158...24,026,313
G
Timd2
T-cell immunoglobulin and mucin domain containing 2
affects expression
ISO
o-Phthalaldehyde affects the expression of TIMD2 mRNA
CTD
PMID:22302311
NCBI chr10:31,060,308...31,101,262
Ensembl chr10:31,060,326...31,094,623
G
Timp1
TIMP metallopeptidase inhibitor 1
affects expression
ISO
o-Phthalaldehyde affects the expression of TIMP1 mRNA
CTD
PMID:22302311
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
G
Tnf
tumor necrosis factor
increases expression
ISO
o-Phthalaldehyde results in increased expression of TNF mRNA
CTD
PMID:21785612
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tp53
tumor protein p53
affects activity
ISO
o-Phthalaldehyde affects the activity of TP53 protein
CTD
PMID:35435491
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Trpm6
transient receptor potential cation channel, subfamily M, member 6
affects expression
ISO
o-Phthalaldehyde affects the expression of TRPM6 mRNA
CTD
PMID:22302311
NCBI chr 1:216,136,407...216,320,523
Ensembl chr 1:216,170,038...216,320,520
G
Ache
acetylcholinesterase
multiple interactions
EXP
vanillin inhibits the reaction [[Fructose co-treated with Streptozocin] results in increased expression of ACHE protein]
CTD
PMID:33823243
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
G
Akr1c2
aldo-keto reductase family 1, member C2
increases expression
ISO
vanillin results in increased expression of AKR1C2 mRNA
CTD
PMID:20491607
NCBI chr17:65,759,778...65,808,013
Ensembl chr17:65,759,788...65,775,764
G
Car1
carbonic anhydrase 1
decreases activity
ISO
vanillin results in decreased activity of CA1 protein
CTD
PMID:19231207
NCBI chr 2:86,829,436...86,872,209
Ensembl chr 2:86,861,897...86,872,208
G
Car2
carbonic anhydrase 2
decreases activity
ISO
vanillin results in decreased activity of CA2 protein
CTD
PMID:19231207
NCBI chr 2:86,741,625...86,756,766
Ensembl chr 2:86,741,626...86,756,818
G
Casp3
caspase 3
multiple interactions
EXP
vanillin inhibits the reaction [Cisplatin results in increased activity of CASP3 protein]; vanillin inhibits the reaction [Methotrexate results in increased activity of CASP3 protein]
CTD
PMID:29216766
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Cat
catalase
multiple interactions
ISO EXP
vanillin inhibits the reaction [potassium bromate results in increased activity of CAT protein] vanillin inhibits the reaction [Cadmium Chloride results in decreased activity of CAT protein] vanillin inhibits the reaction [[Fructose co-treated with Streptozocin] results in decreased activity of CAT protein]
CTD
PMID:26296324 PMID:33823243 PMID:37336463
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions
ISO
vanillin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of CCL2 protein]
CTD
PMID:36416909
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccn2
cellular communication network factor 2
decreases expression
ISO
vanillin results in decreased expression of CCN2 mRNA
CTD
PMID:17178418
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
G
Clk2
CDC-like kinase 2
increases expression
ISO
vanillin results in increased expression of CLK2 mRNA
CTD
PMID:17178418
NCBI chr 2:174,570,614...174,582,645
Ensembl chr 2:174,570,653...174,588,985
G
Cst3
cystatin C
multiple interactions
EXP
vanillin inhibits the reaction [Cisplatin results in increased expression of CST3 protein]; vanillin inhibits the reaction [Methotrexate results in increased expression of CST3 protein]
CTD
PMID:29216766
NCBI chr 3:136,336,923...136,340,796
Ensembl chr 3:136,336,920...136,340,822
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression
ISO
vanillin results in increased expression of CYP1A1 mRNA
CTD
PMID:20491607
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Ddit4
DNA-damage-inducible transcript 4
increases expression
ISO
vanillin results in increased expression of DDIT4 mRNA
CTD
PMID:17178418
NCBI chr20:27,891,989...27,894,088
Ensembl chr20:27,891,998...27,894,105
G
Dnmt3b
DNA methyltransferase 3 beta
decreases expression
ISO
vanillin results in decreased expression of DNMT3B mRNA
CTD
PMID:17178418
NCBI chr 3:142,130,588...142,169,128
Ensembl chr 3:142,130,592...142,169,124
G
Dusp6
dual specificity phosphatase 6
decreases expression
ISO
vanillin results in decreased expression of DUSP6 mRNA
CTD
PMID:17178418
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
G
Faslg
Fas ligand
multiple interactions
EXP
vanillin inhibits the reaction [Cisplatin results in increased expression of FASLG protein]; vanillin inhibits the reaction [Methotrexate results in increased expression of FASLG protein]
CTD
PMID:29216766
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
G
Fbp1
fructose-bisphosphatase 1
affects binding
ISO
vanillin binds to FBP1 protein
CTD
PMID:33823243
NCBI chr17:2,207,271...2,230,076
Ensembl chr17:2,208,031...2,230,071
G
Fgfr2
fibroblast growth factor receptor 2
decreases expression
ISO
vanillin results in decreased expression of FGFR2 mRNA
CTD
PMID:17178418
NCBI chr 1:184,745,418...184,850,655
Ensembl chr 1:184,745,420...184,850,626
G
Fzd2
frizzled class receptor 2
decreases expression
ISO
vanillin results in decreased expression of FZD2 mRNA
CTD
PMID:17178418
NCBI chr10:87,561,866...87,563,776
Ensembl chr10:87,561,326...87,565,334
G
G6pc1
glucose-6-phosphatase catalytic subunit 1
affects binding
ISO
vanillin binds to G6PC1 protein
CTD
PMID:33823243
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
G
G6pd
glucose-6-phosphate dehydrogenase
multiple interactions
ISO
vanillin inhibits the reaction [Cadmium Chloride results in decreased activity of G6PD protein]
CTD
PMID:37336463
NCBI chr X:152,201,081...152,220,863
Ensembl chr X:152,201,098...152,220,801
G
Gapdh
glyceraldehyde-3-phosphate dehydrogenase
multiple interactions
ISO
vanillin inhibits the reaction [Cadmium Chloride results in decreased activity of GAPDH protein]
CTD
PMID:37336463
NCBI chr 4:157,962,312...157,967,158
Ensembl chr 4:157,962,343...157,966,235
G
Gclc
glutamate-cysteine ligase, catalytic subunit
increases expression
ISO
vanillin results in increased expression of GCLC mRNA
CTD
PMID:17178418
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
G
Gclm
glutamate cysteine ligase, modifier subunit
increases expression
ISO
vanillin results in increased expression of GCLM mRNA
CTD
PMID:17178418
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
G
Glo1
glyoxalase 1
multiple interactions
ISO
vanillin inhibits the reaction [Cadmium Chloride results in decreased activity of GLO1 protein]
CTD
PMID:37336463
NCBI chr20:8,663,617...8,681,661
Ensembl chr20:8,662,801...8,681,649
G
Gsr
glutathione-disulfide reductase
multiple interactions
ISO
vanillin inhibits the reaction [Cadmium Chloride results in decreased activity of GSR protein]
CTD
PMID:37336463
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
G
Hmox1
heme oxygenase 1
increases expression
ISO
vanillin results in increased expression of HMOX1 mRNA
CTD
PMID:17178418
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hprt1
hypoxanthine phosphoribosyltransferase 1
decreases mutagenesis
ISO
vanillin results in decreased mutagenesis of HPRT1 gene
CTD
PMID:17178418
NCBI chr X:132,736,175...132,768,149
Ensembl chr X:132,736,096...132,768,154
G
Hspa1b
heat shock protein family A (Hsp70) member 1B
increases expression
ISO
vanillin results in increased expression of HSPA1B mRNA
CTD
PMID:17178418
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
G
Il12b
interleukin 12B
multiple interactions
ISO
vanillin promotes the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of IL12B protein]
CTD
PMID:36416909
NCBI chr10:28,888,832...28,903,802
Ensembl chr10:28,893,008...28,902,903
G
Il18
interleukin 18
multiple interactions
EXP
vanillin inhibits the reaction [Cisplatin results in increased expression of IL18 protein]; vanillin inhibits the reaction [Methotrexate results in increased expression of IL18 protein]
CTD
PMID:29216766
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
G
Il1b
interleukin 1 beta
multiple interactions
ISO
vanillin inhibits the reaction [potassium bromate results in increased expression of IL1B mRNA]
CTD
PMID:26296324
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
multiple interactions
ISO
vanillin inhibits the reaction [potassium bromate results in increased expression of IL6 mRNA]
CTD
PMID:26296324
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Insig1
insulin induced gene 1
decreases expression
ISO
vanillin results in decreased expression of INSIG1 mRNA
CTD
PMID:17178418
NCBI chr 4:7,315,494...7,323,972
Ensembl chr 4:7,315,495...7,323,952
G
Jund
JunD proto-oncogene, AP-1 transcription factor subunit
decreases expression
ISO
vanillin results in decreased expression of JUND mRNA
CTD
PMID:17178418
NCBI chr16:18,734,121...18,735,799
Ensembl chr16:18,734,122...18,735,799
G
Lcn2
lipocalin 2
multiple interactions
EXP
vanillin inhibits the reaction [Cisplatin results in increased expression of LCN2 protein]; vanillin inhibits the reaction [Methotrexate results in increased expression of LCN2 protein]
CTD
PMID:29216766
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
G
Map2k2
mitogen activated protein kinase kinase 2
decreases expression
ISO
vanillin results in decreased expression of MAP2K2 mRNA
CTD
PMID:17178418
NCBI chr 7:8,590,729...8,610,279
Ensembl chr 7:8,580,905...8,610,243
G
Mark4
microtubule affinity regulating kinase 4
decreases expression
ISO
vanillin results in decreased expression of MARK4 mRNA
CTD
PMID:17178418
NCBI chr 1:79,075,353...79,108,882
Ensembl chr 1:79,068,904...79,108,556
G
Mt1
metallothionein 1
multiple interactions
ISO
vanillin inhibits the reaction [potassium bromate results in increased expression of MT1 mRNA]
CTD
PMID:27074584
NCBI chr19:10,826,032...10,827,048
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049
G
Mt2A
metallothionein 2A
increases expression multiple interactions
ISO
vanillin results in increased expression of MT2A mRNA vanillin inhibits the reaction [potassium bromate results in increased expression of MT2 mRNA]
CTD
PMID:20491607 PMID:27074584
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
G
Nos2
nitric oxide synthase 2
multiple interactions
EXP
vanillin inhibits the reaction [Cisplatin results in increased expression of NOS2 protein]; vanillin inhibits the reaction [Methotrexate results in increased expression of NOS2 protein]
CTD
PMID:29216766
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Ppp1r10
protein phosphatase 1, regulatory subunit 10
decreases expression
ISO
vanillin results in decreased expression of PPP1R10 mRNA
CTD
PMID:17178418
NCBI chr20:2,822,995...2,838,125
Ensembl chr20:2,822,995...2,837,611
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
ISO
vanillin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; vanillin inhibits the reaction [potassium bromate results in increased expression of PTGS2 mRNA]
CTD
PMID:17465205 PMID:26296324
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Pygl
glycogen phosphorylase L
affects binding
ISO
vanillin binds to PYGL protein
CTD
PMID:33823243
NCBI chr 6:88,697,598...88,740,260
Ensembl chr 6:88,697,593...88,740,310
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
EXP
vanillin inhibits the reaction [Cisplatin results in increased expression of RELA protein]; vanillin inhibits the reaction [Methotrexate results in increased expression of RELA protein]
CTD
PMID:29216766
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Slc35d2
solute carrier family 35 member D2
decreases expression
ISO
vanillin results in decreased expression of SLC35D2 mRNA
CTD
PMID:17178418
NCBI chr17:987,899...1,019,747
Ensembl chr17:988,157...1,019,743
G
Slc7a11
solute carrier family 7 member 11
increases expression
ISO
vanillin results in increased expression of SLC7A11 mRNA
CTD
PMID:17178418
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
G
Tgfb1i1
transforming growth factor beta 1 induced transcript 1
decreases expression
ISO
vanillin results in decreased expression of TGFB1I1 mRNA
CTD
PMID:17178418
NCBI chr 1:182,828,553...182,835,465
Ensembl chr 1:182,828,544...182,837,080
G
Tnf
tumor necrosis factor
multiple interactions
ISO EXP
vanillin inhibits the reaction [potassium bromate results in increased expression of TNF mRNA] vanillin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased secretion of TNF protein] vanillin inhibits the reaction [Cisplatin results in increased expression of TNF protein]; vanillin inhibits the reaction [Methotrexate results in increased expression of TNF protein]
CTD
PMID:26296324 PMID:29216766 PMID:36416909
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tp53
tumor protein p53
decreases expression
ISO
vanillin results in decreased expression of TP53 mRNA
CTD
PMID:17178418
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Trim16
tripartite motif-containing 16
increases expression
ISO
vanillin results in increased expression of TRIM16 mRNA
CTD
PMID:17178418
NCBI chr10:47,485,982...47,509,010
Ensembl chr10:47,486,297...47,551,907
G
Trpv3
transient receptor potential cation channel, subfamily V, member 3
increases activity
ISO
vanillin results in increased activity of TRPV3 protein
CTD
PMID:16617338
NCBI chr10:57,883,546...57,915,865
Ensembl chr10:57,883,546...57,913,296
G
Ugp2
UDP-glucose pyrophosphorylase 2
increases expression
ISO
vanillin results in increased expression of UGP2 mRNA
CTD
PMID:17178418
NCBI chr14:95,456,330...95,497,483
Ensembl chr14:95,456,330...95,496,830
G
Ugt1a2
UDP glucuronosyltransferase 1 family, polypeptide A2
increases glucuronidation
ISO
UGT1A3 protein results in increased glucuronidation of vanillin
CTD
PMID:15117964
NCBI chr 9:88,791,216...88,808,465
Ensembl chr 9:88,713,184...88,808,465
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all